CEO Welcome Letter
 Donna Janson | Thank you for visiting our website. Your interest today starts an important dialogue with a new kind of dental partner. Novalar is an oral pharmaceutical company focused on finding novel and inventive solutions in dentistry. And our successes are redefining possibility. |
The talented and experienced individuals who make up our Novalar team bring expertise in pharmaceutical, device and biologic development as well as marketing and sales experience in the dental arena from launch to market success. Each member brings their own passion and integrity to a common purpose - finding revolutionary solutions and translating the full value of these to clinical practice.
Our approach to meeting customers' needs is best represented by Novalar's principal product, OraVerse™ (phentolamine mesylate) Injection - a proven solution for reversing the lingering effects of soft tissue anesthesia following dental visits. OraVerse is smart in its simplicity by utilizing existing delivery systems and techniques that are readily incorporated into established treatment regimens. In short, OraVerse defines our unique brand of inventive dentistry. We call it inventistry.
For each customer and every patient, we want to be a redefining presence as the company you look to and the partner you trust. Novalar. Inventistry is here.
Sincerely,
